• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effectiveness and safety of high and low dose NOACs in patients with atrial fibrillation.

作者信息

Marzona Irene, Proietti Marco, Colacioppo Pierluca, Foresta Andreana, Baviera Marta

机构信息

Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Geriatric Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, UK.

出版信息

Eur J Intern Med. 2021 Jun;88:118-122. doi: 10.1016/j.ejim.2021.01.031. Epub 2021 Feb 18.

DOI:10.1016/j.ejim.2021.01.031
PMID:33612349
Abstract
摘要

相似文献

1
Effectiveness and safety of high and low dose NOACs in patients with atrial fibrillation.高剂量和低剂量新型口服抗凝药在房颤患者中的有效性和安全性。
Eur J Intern Med. 2021 Jun;88:118-122. doi: 10.1016/j.ejim.2021.01.031. Epub 2021 Feb 18.
2
Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.伴有单一卒中危险因素的房颤患者中标准剂量非维生素 K 拮抗剂口服抗凝剂和华法林的有效性和安全性：一项全国性队列研究。
JAMA Cardiol. 2017 Aug 1;2(8):872-881. doi: 10.1001/jamacardio.2017.1883.
3
Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.当代口服抗凝剂在亚洲非瓣膜性心房颤动患者中的疗效和安全性。
Stroke. 2019 Aug;50(8):2245-2249. doi: 10.1161/STROKEAHA.119.025536. Epub 2019 Jun 18.
4
Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation.新型口服抗凝药用于非瓣膜性心房颤动患者卒中预防的成本效益分析
Curr Cardiol Rep. 2015 Aug;17(8):61. doi: 10.1007/s11886-015-0618-4.
5
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients.非瓣膜性心房颤动患者口服抗凝剂的有效性和安全性。
Stroke. 2018 Dec;49(12):2933-2944. doi: 10.1161/STROKEAHA.118.020232.
6
Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.非维生素K拮抗剂口服抗凝药在心房颤动患者中的应用：来自专科心房颤动诊所的见解
Int J Clin Pract. 2015 Nov;69(11):1341-8. doi: 10.1111/ijcp.12712. Epub 2015 Aug 3.
7
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.低剂量非维生素K拮抗剂口服抗凝药与华法林在房颤患者中的有效性和安全性：倾向评分加权的全国队列研究
BMJ. 2017 Feb 10;356:j510. doi: 10.1136/bmj.j510.
8
Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation.新型口服抗凝剂在非瓣膜性心房颤动女性患者中的间接比较
J Womens Health (Larchmt). 2017 Mar;26(3):214-221. doi: 10.1089/jwh.2016.5892. Epub 2016 Nov 21.
9
Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.非维生素 K 依赖性口服抗凝剂（NOACs）在伴有心房颤动的慢性肾脏病患者中的应用。
Thromb Res. 2017 Jul;155:38-47. doi: 10.1016/j.thromres.2017.04.027. Epub 2017 May 4.
10
Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.新型口服抗凝药用于房颤患者卒中预防的成本效益：取决于华法林抗凝控制的质量
Pharmacoeconomics. 2015 Apr;33(4):395-408. doi: 10.1007/s40273-014-0246-7.

引用本文的文献

1
Effectiveness and Safety of Dose-Specific DOACs in Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.特定剂量直接口服抗凝剂在房颤患者中的有效性和安全性：一项系统评价与网状Meta分析
Cardiovasc Ther. 2025 Jan 6;2025:9923772. doi: 10.1155/cdr/9923772. eCollection 2025.
2
Real-world national trends and influencing factors preference of non-vitamin K antagonist oral anticoagulants in China.中国非维生素K拮抗剂口服抗凝药的真实世界全国趋势及影响因素偏好
Front Med (Lausanne). 2023 Nov 21;10:1258536. doi: 10.3389/fmed.2023.1258536. eCollection 2023.
3
Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document.
老年和体弱房颤患者直接口服抗凝剂的使用与处方：多学科共识文件
J Pers Med. 2022 Mar 15;12(3):469. doi: 10.3390/jpm12030469.